The recall comes after the maker determined the drug may not dissolve or release its active ingredient in a way that meets ...
A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...
The team found a notable correlation between genetics that predicted low cholesterol and a lower risk of dementia, suggesting ...
The FDA has issued a recall of over 140,000 bottles of cholesterol medication due to "failed dissolution specifications." ...
New Jersey-based Ascend Laboratories has voluntarily recalled 141,984 bottles of atorvastatin calcium, a cholesterol-lowering ...
Cholesterol contributes to brain and vascular health, but excessive levels can cause blockages that limit blood flow and ...
PennyGem on MSN
FDA Issues Recall as 142,000 Cholesterol Bottles Flagged – 47 Million U.S. Patients Affected
Thousands of Americans who rely on cholesterol-lowering medication are now facing uncertainty after a major recall of ...
The FDA announced a nationwide recall of over 140,000 bottles of a prescription cholesterol medication due to “failed ...
The problem with the liver’s strategy of dumping excess cholesterol into the gut is that some of it ends up re-absorbed back into the body ...
Common cholesterol-lowering drugs may reduce risk of developing dementia: StudyLower cholesterol levels may play a key role ...
A new study led by the University of Bristol, involving more than one million participants, has found that having lower cholesterol levels may reduce the risk of developing dementia. The study, led by ...
The recall is due to “failed dissolution specifications,” which is when a drug does not dissolve the way it was supposed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback